Board of Directors

Renee Selman
Renee Selman Director

Renee Selman joined the Avation Medical Board as a Director in December 2020.

Renee is an accomplished pharmaceutical/medical device/healthcare services Senior Executive with extensive global and domestic experience in the healthcare industry. Her experience spans both public, private equity and start up environments and includes progressive assignments in general management with responsibility for commercialization of US and global products, R&D, regulatory strategy, strategic partnership development and deal making. In addition, Renee has extensive Board experience. Renee currently serves on the board of the Hunterdon Medical System, Career Wardrobe, and FEMSelect. Other relevant past board experience includes the Drug Information Association, Purdue University, and a small commercial private medical device company. Renee is also an active member of Robin Hood Ventures angel investing group in Philadelphia.

Currently Renee serves as CEO of FEMSelect. FEMSelect is an early commercial stage medical device company with an offering in the women’s health space.

(2016-2018) Renee served as the interim Chief Commercial Officer of Agile Therapeutics. Agile is a public, pre-revenue women’s health company that recently received FDA approval.

(2010-2015) Renee served as President of Catalina Health (division of Catalina Marketing) which was divested from Catalina and purchased by inVentiv Health (October 2013) and merged with an inVentiv business, Adheris. Renee was named the President of the newly combined entity Adheris Health and was responsible for the day-to-day management of the business.

Previously, Renee was Worldwide President of Ethicon Women’s Health and Urology (division of J&J) 2005-2010, a procedurally focused device company dedicated to improving the standard of care in a broad range of pelvic health conditions. Renee led an organizational turnaround growing sales 45%, improving net income and growing key emerging markets by more than 20% through market development. During her tenure at EWHU, Renee led multiple business development activities including acquisitions and licensing agreements. These changes and other commercial market innovations set the course for EWHU to double in size to reach approximately $500MM in less than 5 years. In this role, Renee led a cross-functional global board including R&D, medical affairs, operations, and other shared functions.

Renee has also served as the VP Sales & Marketing for J&J Wound Management. In this capacity Renee led a 200-person Sales & Marketing team growing the business over 20% each year while advancing 30% of the management team into positions of greater responsibility. While in the pharmaceutical division, Renee held multiple positions of increasing responsibility involving Sales, Marketing, and New Product Development. These experiences spanned multiple therapeutic areas and specialties. While at Ortho Pharmaceutical, Renee managed the launch of Ortho Evra®, exceeding all key product launch metrics and gaining significant direct to consumer experienceexperience.

She is a graduate of Purdue University with a major in Business and a minor in Chemistry. Renee enjoys traveling, running, cycling and scuba diving. She resides in Philadelphia with her husband.